The National Institutes of Health announced the members of the Interagency Pain Research Coordinating Committee, which was created by a directive from Congress through the Affordable Care Act, according to a NIH news release.
The committee's goal is to identify critical gaps in basic and clinical research on the symptoms, causes and treatment of pain and to recommend federal research programs in these areas. Story Landis, PhD, director of NIH's National Institute of Neurological Disorders and Stroke will chair the committee. Members will serve overlapping three-year terms. The committee is expected to meet at least once a year, and the first meeting is schedule for March 27. A complete list of committee members follows.
Federal agency representatives:
• Martha J. Somerman, DDS, PhD, director of the National Institute of Dental and Craniofacial Research, part of the NIH.
• Charles G. Helmick III, MD, senior medical epidemiologist with the Arthritis Program at the National Center for Chronic Disease Prevention and Health Promotion, part of the CDC.
• Audrey N. Kusiak, PhD, portfolio manager in the Rehabilitation Research and Development Service at the Department of Veterans Affairs, Office of Research and Development
• Bob Andrew Rappaport, MD, director of the Division of Anesthesia, Analgesia and Addiction Products in the Center for Drug Evaluation and Research of the FDA
• Richard Ricciardi, PhD, health scientist in the Center for Primary Care, Prevention and Clinical Partnerships at HHS' Agency for Healthcare Research and Quality, and a pediatric and family nurse practitioner
• Maj. Gen. Richard W. Thomas, MD, DDS, commanding general, Western Region Medical Command
Non-federal researchers appointed to the committee are:
• Ronald Dubner, DDS, PhD, professor at the University of Maryland School of Dentistry, Baltimore
• Carmen R. Green, MD, professor of anesthesiology, obstetrics and gynecology, and health management and policy at the University of Michigan's schools of Medicine and Public Health, Ann Arbor.
• Sean Mackey, MD, PhD, chief of the Division of Pain Management and associate professor of anesthesiology, neurosciences and neurology at Stanford University School of Medicine
• Christine A. Miaskowski, RN, PhD, an American Cancer Society clinical research professor and the associate dean for academic affairs at the University of California San Francisco School of Nursing and the Sharon A. Lamb Endowed Chair in Symptom Management Research in the Department of Physiological Nursing
• Michael A. Moskowitz, MD, professor of neurology at Harvard Medical School affiliated with the Harvard-MIT Division of Health Science and Technology, Boston
• Wally R. Smith, MD, professor and chairman of the Division of Quality Health Care and scientific director for the Center on Health Disparities at Virginia Commonwealth University, Richmond
Appointees from public advocacy organizations:
• Terrie Cowley, president and co-founder of the TMJ Association, Milwaukee
• Elizabeth B. Gilbertson, chief of strategy for Unite Here Health, Aurora, Ill.
• Tamara K. Liller, president of the National Fibromyalgia Partnership, Linden, Va.
• Tina M. Tockarshewsky, president and chief executive officer of The Neuropathy Association, New York City
• Mary Vargas, JD, chair of the board of directors for the American Pain Foundation, Baltimore, and partner at Stein & Vargas, LLP
• Christin Veasley, executive director for the National Vulvodynia Association, Silver Spring, Md.
Related Articles on Pain Management:
The Future of Evidence-Based Medicine in Pain Management: Q&A With Dr. Laxmaiah Manchikanti of the American Society of Interventional Pain Physicians
FDA Approves Medasys Implantable Programmable Drug Pump for Pain Management
10 Trends in ASC Pain Management Case Revenue Based on Facility Size From 2007-2010
Federal agency representatives:
• Martha J. Somerman, DDS, PhD, director of the National Institute of Dental and Craniofacial Research, part of the NIH.
• Charles G. Helmick III, MD, senior medical epidemiologist with the Arthritis Program at the National Center for Chronic Disease Prevention and Health Promotion, part of the CDC.
• Audrey N. Kusiak, PhD, portfolio manager in the Rehabilitation Research and Development Service at the Department of Veterans Affairs, Office of Research and Development
• Bob Andrew Rappaport, MD, director of the Division of Anesthesia, Analgesia and Addiction Products in the Center for Drug Evaluation and Research of the FDA
• Richard Ricciardi, PhD, health scientist in the Center for Primary Care, Prevention and Clinical Partnerships at HHS' Agency for Healthcare Research and Quality, and a pediatric and family nurse practitioner
• Maj. Gen. Richard W. Thomas, MD, DDS, commanding general, Western Region Medical Command
Non-federal researchers appointed to the committee are:
• Ronald Dubner, DDS, PhD, professor at the University of Maryland School of Dentistry, Baltimore
• Carmen R. Green, MD, professor of anesthesiology, obstetrics and gynecology, and health management and policy at the University of Michigan's schools of Medicine and Public Health, Ann Arbor.
• Sean Mackey, MD, PhD, chief of the Division of Pain Management and associate professor of anesthesiology, neurosciences and neurology at Stanford University School of Medicine
• Christine A. Miaskowski, RN, PhD, an American Cancer Society clinical research professor and the associate dean for academic affairs at the University of California San Francisco School of Nursing and the Sharon A. Lamb Endowed Chair in Symptom Management Research in the Department of Physiological Nursing
• Michael A. Moskowitz, MD, professor of neurology at Harvard Medical School affiliated with the Harvard-MIT Division of Health Science and Technology, Boston
• Wally R. Smith, MD, professor and chairman of the Division of Quality Health Care and scientific director for the Center on Health Disparities at Virginia Commonwealth University, Richmond
Appointees from public advocacy organizations:
• Terrie Cowley, president and co-founder of the TMJ Association, Milwaukee
• Elizabeth B. Gilbertson, chief of strategy for Unite Here Health, Aurora, Ill.
• Tamara K. Liller, president of the National Fibromyalgia Partnership, Linden, Va.
• Tina M. Tockarshewsky, president and chief executive officer of The Neuropathy Association, New York City
• Mary Vargas, JD, chair of the board of directors for the American Pain Foundation, Baltimore, and partner at Stein & Vargas, LLP
• Christin Veasley, executive director for the National Vulvodynia Association, Silver Spring, Md.
Related Articles on Pain Management:
The Future of Evidence-Based Medicine in Pain Management: Q&A With Dr. Laxmaiah Manchikanti of the American Society of Interventional Pain Physicians
FDA Approves Medasys Implantable Programmable Drug Pump for Pain Management
10 Trends in ASC Pain Management Case Revenue Based on Facility Size From 2007-2010